Cargando…
Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy
Peptidoglycan degrading enzymes are of increasing interest as antibacterial agents, especially against multi-drug resistant pathogens. Herein we present a review about the biological features of virion-associated lysins and endolysins, phage-derived enzymes that have naturally evolved to compromise...
Autores principales: | Oliveira, Hugo, São-José, Carlos, Azeredo, Joana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024856/ https://www.ncbi.nlm.nih.gov/pubmed/29844287 http://dx.doi.org/10.3390/v10060292 |
Ejemplares similares
-
Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials
por: São-José, Carlos
Publicado: (2018) -
Correction: São-José, C. Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials. Antibiotics 2018, 7, 29
por: São-José, Carlos
Publicado: (2018) -
Unexploited opportunities for phage therapy
por: Oliveira, Hugo, et al.
Publicado: (2015) -
Complete Genome Sequences of Eight Phages Infecting Enterotoxigenic Escherichia coli in Swine
por: Ferreira, Alice, et al.
Publicado: (2020) -
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization
por: Mandal, Santi M., et al.
Publicado: (2014)